Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Department of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Medicine (Baltimore). 2022 Nov 4;101(44):e31545. doi: 10.1097/MD.0000000000031545.
This study aimed to evaluate the feasibility of performing endoscopic ultrasound-guided hepaticogastrostomy using a 22-gauge fine-needle aspiration needle. This was a single-center retrospective study. Fourteen patients who underwent endoscopic ultrasound-guided hepaticogastrostomy with a 22-gauge fine-needle aspiration needle were examined. Fourteen eligible patients were included in this study. The age of patients ranged from 55 to 93 years, with a median of 76 years. Of patients with existing underlying diseases, there were 8 cases of pancreatic cancer (57.1%), 2 cases of metastatic liver tumor (14.3%), 2 cases of bile duct stones (14.3%), 1 case of hilar cholangiocarcinoma (7.1%), and 1 case of gallbladder cancer (7.1%). Regarding gastrointestinal anatomy, there were 11 cases (78.6%) of normal and 3 cases (21.4%) of gastric resection with Roux-en-Y. Reasons for endoscopic ultrasound-guided hepaticogastrostomy were duodenal obstruction in 7 cases (50.0%), surgically altered anatomy in 3 cases (21.4%), and 4 cases (28.6%) of failed endoscopic retrograde cholangiopancreatography. Technical success was achieved in 11 cases (78.6%). Subsequently, 11 cases of technical success were analyzed. There were 5 cases of puncturing B2 (45.5%). The puncture bile duct diameter ranged from 3.1 to 5.7 mm, with a median of 4.4 mm. endoscopic ultrasound-guided antegrade procedures was combined with endoscopic ultrasound-guided hepaticogastrostomy in 2 cases (18.2%). Clinical success was achieved in all the cases. The procedure time ranged from 15 to 93 minutes, with a median duration of 35 minutes. Regarding the type of stent placed in hepaticogastrostomy, a plastic stent was placed in 10 cases (90.9%) and a metal stent was placed in 1 case (9.1%). Early adverse events occurred in 4 cases (36.4%), and all of these cases developed biliary peritonitis, late adverse events occurred in 1 case (9.1%), this was biloma. A change to a 0.025-inch guidewire during the procedure was required in 8 cases (72.7%). Esophageal puncture was not performed. endoscopic ultrasound-guided hepaticogastrostomy using a 22-gauge fine-needle aspiration needle is effective. However, in 72.7% of the cases started using the 0.018-inch guidewire, the guidewire was exchanged for a 0.025-inch guidewire during procedure.
本研究旨在评估使用 22 号细针抽吸针进行内镜超声引导下肝胃吻合术的可行性。这是一项单中心回顾性研究。对 14 例行内镜超声引导下肝胃吻合术的患者进行了检查。本研究共纳入 14 例符合条件的患者。患者年龄 55 至 93 岁,中位年龄为 76 岁。在存在基础疾病的患者中,有 8 例胰腺癌(57.1%)、2 例转移性肝肿瘤(14.3%)、2 例胆管结石(14.3%)、1 例肝门部胆管癌(7.1%)和 1 例胆囊癌(7.1%)。关于胃肠道解剖结构,有 11 例(78.6%)为正常,3 例(21.4%)为胃切除术伴 Roux-en-Y。行内镜超声引导下肝胃吻合术的原因是十二指肠梗阻 7 例(50.0%)、手术改变解剖结构 3 例(21.4%)和内镜逆行胰胆管造影术失败 4 例(28.6%)。技术成功率为 11 例(78.6%)。随后对 11 例技术成功的患者进行分析。有 5 例穿刺 B2(45.5%)。穿刺胆管直径为 3.1 至 5.7mm,中位数为 4.4mm。2 例(18.2%)合并内镜超声引导下顺行操作。所有病例均获得临床成功。操作时间为 15 至 93 分钟,中位数为 35 分钟。关于肝胃吻合术中放置的支架类型,10 例(90.9%)放置塑料支架,1 例(9.1%)放置金属支架。早期不良事件发生 4 例(36.4%),均为胆漏,晚期不良事件发生 1 例(9.1%),为胆汁瘤。8 例(72.7%)在操作过程中需要更换为 0.025 英寸导丝。未进行食管穿刺。使用 22 号细针抽吸针进行内镜超声引导下肝胃吻合术是有效的。然而,在 72.7%的病例中,开始使用 0.018 英寸导丝,在操作过程中导丝更换为 0.025 英寸导丝。